Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 273

Similar articles for PubMed (Select 18666236)


Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.

Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D, Kerksiek A, van Kruchten R, Maeda N, Staels B, van Bilsen M, Shiri-Sverdlov R, Hofker MH.

Hepatology. 2008 Aug;48(2):474-86. doi: 10.1002/hep.22363.


LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.

Bieghs V, Van Gorp PJ, Wouters K, Hendrikx T, Gijbels MJ, van Bilsen M, Bakker J, Binder CJ, Lütjohann D, Staels B, Hofker MH, Shiri-Sverdlov R.

PLoS One. 2012;7(1):e30668. doi: 10.1371/journal.pone.0030668. Epub 2012 Jan 25.


The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice.

Bieghs V, Hendrikx T, van Gorp PJ, Verheyen F, Guichot YD, Walenbergh SM, Jeurissen ML, Gijbels M, Rensen SS, Bast A, Plat J, Kalhan SC, Koek GH, Leitersdorf E, Hofker MH, Lütjohann D, Shiri-Sverdlov R.

Gastroenterology. 2013 Jan;144(1):167-178.e1. doi: 10.1053/j.gastro.2012.09.062. Epub 2012 Oct 3.


Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.

Bieghs V, Wouters K, van Gorp PJ, Gijbels MJ, de Winther MP, Binder CJ, Lütjohann D, Febbraio M, Moore KJ, van Bilsen M, Hofker MH, Shiri-Sverdlov R.

Gastroenterology. 2010 Jun;138(7):2477-86, 2486.e1-3. doi: 10.1053/j.gastro.2010.02.051. Epub 2010 Mar 2.


Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.

Savard C, Tartaglione EV, Kuver R, Haigh WG, Farrell GC, Subramanian S, Chait A, Yeh MM, Quinn LS, Ioannou GN.

Hepatology. 2013 Jan;57(1):81-92. doi: 10.1002/hep.25789.


A high-protein diet is anti-steatotic and has no pro-inflammatory side effects in dyslipidaemic APOE2 knock-in mice.

Garcia Caraballo SC, Comhair TM, Dejong CH, Lamers WH, Köhler SE.

Br J Nutr. 2014 Oct 28;112(8):1251-65. doi: 10.1017/S0007114514001986. Epub 2014 Aug 27.


Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice.

Subramanian S, Goodspeed L, Wang S, Kim J, Zeng L, Ioannou GN, Haigh WG, Yeh MM, Kowdley KV, O'Brien KD, Pennathur S, Chait A.

J Lipid Res. 2011 Sep;52(9):1626-35. doi: 10.1194/jlr.M016246. Epub 2011 Jun 20.


Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice.

Depner CM, Torres-Gonzalez M, Tripathy S, Milne G, Jump DB.

J Nutr. 2012 Aug;142(8):1495-503. doi: 10.3945/jn.112.158865. Epub 2012 Jun 27.


Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat.

Comhair TM, Garcia Caraballo SC, Dejong CH, Lamers WH, Köhler SE.

Nutr Metab (Lond). 2011 Jan 24;8:4. doi: 10.1186/1743-7075-8-4.


Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.

Larter CZ, Yeh MM, Haigh WG, Van Rooyen DM, Brooling J, Heydet D, Nolan CJ, Teoh NC, Farrell GC.

Obesity (Silver Spring). 2013 Jun;21(6):1189-99. doi: 10.1002/oby.20123. Epub 2013 May 10.


Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.

Kong B, Luyendyk JP, Tawfik O, Guo GL.

J Pharmacol Exp Ther. 2009 Jan;328(1):116-22. doi: 10.1124/jpet.108.144600. Epub 2008 Oct 23.


Macrophage specific caspase-1/11 deficiency protects against cholesterol crystallization and hepatic inflammation in hyperlipidemic mice.

Hendrikx T, Bieghs V, Walenbergh SM, van Gorp PJ, Verheyen F, Jeurissen ML, Steinbusch MM, Vaes N, Binder CJ, Koek GH, Stienstra R, Netea MG, Hofker MH, Shiri-Sverdlov R.

PLoS One. 2013 Dec 2;8(12):e78792. doi: 10.1371/journal.pone.0078792. eCollection 2013.


Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.

Gupte AA, Liu JZ, Ren Y, Minze LJ, Wiles JR, Collins AR, Lyon CJ, Pratico D, Finegold MJ, Wong ST, Webb P, Baxter JD, Moore DD, Hsueh WA.

Hepatology. 2010 Dec;52(6):2001-11. doi: 10.1002/hep.23941. Epub 2010 Oct 11.


The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model.

Jia X, Naito H, Yetti H, Tamada H, Kitamori K, Hayashi Y, Yamagishi N, Wang D, Yanagiba Y, Ito Y, Wang J, Tanaka N, Ikeda K, Yamori Y, Nakajima T.

Life Sci. 2012 Jun 14;90(23-24):934-43. doi: 10.1016/j.lfs.2012.04.029. Epub 2012 Apr 30.


Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.

Kassel KM, Sullivan BP, Cui W, Copple BL, Luyendyk JP.

Am J Pathol. 2012 Oct;181(4):1287-95. doi: 10.1016/j.ajpath.2012.06.011. Epub 2012 Jul 26.


Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.

Shiri-Sverdlov R, Wouters K, van Gorp PJ, Gijbels MJ, Noel B, Buffat L, Staels B, Maeda N, van Bilsen M, Hofker MH.

J Hepatol. 2006 Apr;44(4):732-41. Epub 2005 Dec 20.


A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein.

Yimin, Furumaki H, Matsuoka S, Sakurai T, Kohanawa M, Zhao S, Kuge Y, Tamaki N, Chiba H.

Lab Invest. 2012 Feb;92(2):265-81. doi: 10.1038/labinvest.2011.159. Epub 2011 Nov 7.


Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.

Karavia EA, Papachristou DJ, Kotsikogianni I, Giopanou I, Kypreos KE.

FEBS J. 2011 Sep;278(17):3119-29. doi: 10.1111/j.1742-4658.2011.08238.x. Epub 2011 Aug 2.


Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.

Wang C, Cui Y, Li C, Zhang Y, Xu S, Li X, Li H, Zhang X.

Lipids Health Dis. 2013 Nov 4;12:165. doi: 10.1186/1476-511X-12-165.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk